Alice Renard
Board Director
Alice is a Partner of Syncona Investment Management Ltd
Alice also works closely with Syncona portfolio company Anaveon. Alice serves as an Observer on the Board of Purespring and Anaveon.
Prior to joining Syncona, Alice was an Investment Banking Analyst within Barclays’ Healthcare Corporate Finance and M&A team, where she worked on transactions involving pharmaceutical and other healthcare companies. Prior to Barclays, Alice worked briefly at AbbVie and Janssen.
Alice holds a Doctorate degree in Pharmacy from the University of Lille 2 in France. Alice also holds a Masters in International Health Policy & Health Economics from the London School of Economics.